Ajanta Pharma - Quaterly Results

10 May 2022 Evaluate
The company's total revenue for the quarter ended March 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 7656.30 millions.A slender decline of -12.88% was recorded to Rs. 1348.40  millions from Rs. 1547.80 millions in the corresponding previous quarter.Operating profit for the quarter ended March 2022 decreased to 2155.70 millions as compared to 2484.10 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 7656.30 7480.70 2.35 31406.40 27185.90 15.52 31406.40 27185.90 15.52
Other Income 284.20 13.30 2036.84 1397.30 1035.70 34.91 1397.30 1035.70 34.91
PBIDT 2155.70 2484.10 -13.22 10306.20 10204.80 0.99 10306.20 10204.80 0.99
Interest 71.80 21.80 229.36 91.20 69.00 32.17 91.20 69.00 32.17
PBDT 2083.90 2462.30 -15.37 10215.00 10135.80 0.78 10215.00 10135.80 0.78
Depreciation 300.90 294.80 2.07 1209.60 1114.90 8.49 1209.60 1114.90 8.49
PBT 1783.00 2167.50 -17.74 9005.40 9020.90 -0.17 9005.40 9020.90 -0.17
TAX 434.60 619.70 -29.87 1806.80 2264.50 -20.21 1806.80 2264.50 -20.21
Deferred Tax -34.90 -65.80 -46.96 95.10 97.70 -2.66 95.10 97.70 -2.66
PAT 1348.40 1547.80 -12.88 7198.60 6756.40 6.54 7198.60 6756.40 6.54
Equity 171.70 173.90 -1.27 171.70 173.90 -1.27 171.70 173.90 -1.27
PBIDTM(%) 28.16 33.21 -15.21 32.82 37.54 -12.58 32.82 37.54 -12.58

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×